GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$7.32M
Contract actions56
Awards / PIIDs41
Federal customers4
Contracting offices12
Average action$130.7K
Active fiscal years6
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $7.32M in net contract obligations to NOVARTIS PHARMACEUTICALS CORPORATION across 56 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

NOVARTIS PHARMACEUTICALS CORPORATION contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$8.64M
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$919.4K32
FY 2020$7.79M172+747.2%
FY 2021$1.42M102−81.8%
FY 2022$7.39M32+421.5%
FY 2023-$18.84M31−354.8%
FY 2025$8.64M203+145.9%

04 / Federal Customers

Which federal agencies buy from NOVARTIS PHARMACEUTICALS CORPORATION?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
3600$12.80M44174.9%
97DH$402.6K15.5%
2100$23.5K20.3%
7505-$5.91M9-80.8%

05 / Contracting Offices

Which contracting offices buy from NOVARTIS PHARMACEUTICALS CORPORATION?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
325412PHARMACEUTICAL PREPARATION MANUFACTURING$13.23M473180.8%
541711RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY-$5.91M91-80.8%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6505DRUGS AND BIOLOGICALS$12.83M462175.3%
6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$402.6K115.5%
AN92R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)-$5.91M91-80.8%

08 / Competition Pattern

How was NOVARTIS PHARMACEUTICALS CORPORATION’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Competed$6.89M53
Not available for competition$23.5K2
Other / unknown$402.6K1

09 / Recent Contract Awards

What contract actions were recorded most recently for NOVARTIS PHARMACEUTICALS CORPORATION?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
36C24525N1028Sep 24, 2025$33.8KVETERANS AFFAIRS, DEPARTMENT OF 245-NETWORK CONTRACT OFFICE 5 (36C245)3254126505

10 / Interpreting the Profile

How should you evaluate NOVARTIS PHARMACEUTICALS CORPORATION as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.